A detailed history of Fmr LLC transactions in Repligen Corp stock. As of the latest transaction made, Fmr LLC holds 1,444,788 shares of RGEN stock, worth $208 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,444,788
Previous 2,257,789 36.01%
Holding current value
$208 Million
Previous $415 Million 56.14%
% of portfolio
0.01%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$120.0 - $182.95 $97.6 Million - $149 Million
-813,001 Reduced 36.01%
1,444,788 $182 Million
Q1 2024

May 13, 2024

BUY
$170.78 - $208.42 $64.1 Million - $78.2 Million
375,273 Added 19.93%
2,257,789 $415 Million
Q4 2023

Feb 13, 2024

SELL
$114.17 - $185.35 $39 Million - $63.2 Million
-341,245 Reduced 15.35%
1,882,516 $338 Million
Q3 2023

Nov 13, 2023

SELL
$138.78 - $176.51 $33.6 Million - $42.8 Million
-242,430 Reduced 9.83%
2,223,761 $354 Million
Q2 2023

Aug 11, 2023

BUY
$138.42 - $180.31 $62.2 Million - $81.1 Million
449,547 Added 22.29%
2,466,191 $349 Million
Q1 2023

May 11, 2023

BUY
$154.26 - $198.1 $156 Million - $201 Million
1,013,380 Added 101.01%
2,016,644 $340 Million
Q4 2022

Feb 13, 2023

BUY
$162.42 - $220.56 $137 Million - $186 Million
845,519 Added 536.0%
1,003,264 $170 Million
Q3 2022

Nov 10, 2022

BUY
$160.42 - $256.21 $24.8 Million - $39.7 Million
154,889 Added 5423.28%
157,745 $29.5 Million
Q2 2022

Aug 12, 2022

SELL
$140.68 - $188.02 $53.9 Million - $72 Million
-382,909 Reduced 99.26%
2,856 $464,000
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $594,468 - $951,356
3,688 Added 0.97%
385,765 $72.6 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $561,038 - $689,929
-2,266 Reduced 0.59%
382,077 $101 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $186,979 - $311,241
-960 Reduced 0.25%
384,343 $111 Million
Q2 2021

Aug 13, 2021

BUY
$165.87 - $220.95 $63.9 Million - $85.1 Million
385,303 New
385,303 $76.9 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.98B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.